796851-66-6

Basic information

• Product Name: Benzoic acid, 4-chloro-2-(2-ethoxy-2-oxoethoxy)-, methyl ester
• CAS NO: 796851-66-6
• Molecular Formula: C12H13ClO5
• Molecular Weight: 272.685
• Mol File: 796851-66-6.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-chloro-2-(2-ethoxy-2-oxoethoxy)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-chloro-2-(2-ethoxy-2-oxoethoxy)-, methyl ester(796851-66-6)
• EPA Substance Registry System: Benzoic acid, 4-chloro-2-(2-ethoxy-2-oxoethoxy)-, methyl ester(796851-66-6)

Safety Data

• Hazardous Substances Data: 796851-66-6(Hazardous Substances Data)

Upstream product

• 22717-55-1 methyl 4-chloro-2-hydroxybenzoate 
• 105-36-2 ethyl bromoacetate 
• 5106-98-9 4-chlorosalicylic acid 

Downstream Products

• 3260-78-4 6-chlorobenzofuran-3(2H)-one 
• 401622-26-2 2-(carboxymethoxy)-4-chloro-benzoic acid 

Relevant articles and documents

(AZA)INDOLE-, BENZOTHIOPHENE-, AND BENZOFURAN-3-SULFONAMIDES

Disclosed are sulfonamide compounds with GPR17 modulating properties, which are useful for treating or preventing a variety of CNS and other diseases, in particular for preventing and treating myelinating diseases or disorders.

BENZOFURANYL- AND BENZOTHIENYL- PIPERAZINYL QUINOLINES AND METHODS OF THEIR USE

Benzofuranyl- and benzothienyl-piperzinyl quinoline derivatives and compositions containing such compounds are disclosed. Methods of using benzofuranyl- and benzothienyl-piperzinyl quinoline derivatives and compositions containing such composition in the treatment and/or prevention of serotonin-related disorders, such as depression and anxiety, are also disclosed. In addition, processes for the preparation of benzofuranyl- and benzothienyl-piperzinyl quinoline derivatives are disclosed.

BENZOFURANYL-AND BENZOTHIENYL-PIPERAZINYL QUINOLINES AND METHODS OF THEIR USE

Benzofuranyl-and benzothienyl-piperzinyl quinoline derivatives and compositions containing such compounds are disclosed. Methods of using benzofuranyl- and benzothienyl-piperzinyl quinoline derivatives and compositions containing such composition in the treatment and/or prevention of serotonin-related disorders, such as depression and anxiety, are also disclosed. In addition, processes for the preparation of benzofuranyl- and benzothienyl-piperzinyl quinoline derivatives are disclosed.